Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Cecilia Nilsson, Ida Johansson, Cecilia Ahlin, Sten Thorstenson, Rose-Marie Amini, Marit Holmqvist, Leif Bergkvist, Ingrid Hedenfalk & Marie-Louise Fjällskog. (2013) Molecular subtyping of male breast cancer using alternative definitions and its prognostic impact. Acta Oncologica 52:1, pages 102-109.
Read now
Read now
Articles from other publishers (23)
C.L. Rutherford, D. Goodman & A. Lannigan. (2022) A systematic literature review of the management, oncological outcomes and psychosocial implications of male breast cancer. European Journal of Surgical Oncology 48:10, pages 2104-2111.
Crossref
Crossref
Li‐Ping Zhang, Hui Lin & Ai‐Jing Wang. (2022) Development and validation of a nomogram to predict survival for advanced male breast cancer. Andrologia 54:8.
Crossref
Crossref
Anna Maria Annoni & Claudia Longhini. (2022) Investigating men’s motivations to engage in genetic screening for BRCA1 and BRCA2 mutations. PLOS ONE 17:3, pages e0265387.
Crossref
Crossref
Nicole Ernstmann, Evamarie Midding, Sarah Halbach, Rachel Würstlein, Rainer Weber, Sherin Christmann & Christoph Kowalski. (2020) Brustkrebs beim Mann – die Sicht der beteiligten Berufsgruppen auf die multiprofessionelle Versorgung einer seltenen Erkrankung. Senologie - Zeitschrift für Mammadiagnostik und -therapie 17:04, pages 266-271.
Crossref
Crossref
France Labrèche, Mark S. Goldberg, Dana Hashim & Elisabete Weiderpass. 2020. Occupational Cancers. Occupational Cancers
417
438
.
Siying Chen, Yang Liu, Jin Yang, Qingqing Liu, Haisheng You, Yalin Dong & Jun Lyu. (2019) Development and Validation of a Nomogram for Predicting Survival in Male Patients With Breast Cancer. Frontiers in Oncology 9.
Crossref
Crossref
Malin Grönberg, Cecilia Nilsson, Ida Markholm, Ingrid Hedenfalk, Carl Blomqvist, Lars Holmberg, Eva Tiensuu Janson & Marie-Louise Fjällskog. (2018) Ghrelin expression is associated with a favorable outcome in male breast cancer. Scientific Reports 8:1.
Crossref
Crossref
Kang Wang, Qiu-Juan Wang, Yong-Fu Xiong, Yang Shi, Wen-Jing Yang, Xiang Zhang & Hong-Yuan Li. (2018) Survival Comparisons Between Early Male and Female Breast Cancer Patients. Scientific Reports 8:1.
Crossref
Crossref
David M. Euhus. (2017) Management of Rare Breast Tumors and Male Breast Cancer. Current Breast Cancer Reports 9:2, pages 156-164.
Crossref
Crossref
Ian FentimanIan Fentiman. 2017. Male Breast Cancer. Male Breast Cancer
145
165
.
Min-Young Choi, Se Kyung Lee, Jeong Eon Lee, Hyung Seok Park, Seung Taek Lim, Yongsik Jung, Byung Kyun Ko & Seok Jin Nam. (2016) Characterization of Korean Male Breast Cancer Using an Online Nationwide Breast-Cancer Database. Medicine 95:16, pages e3299.
Crossref
Crossref
Tricia L. da Silva. (2016) Male breast cancer: Medical and psychological management in comparison to female breast cancer. A review. Cancer Treatment Communications 7, pages 23-34.
Crossref
Crossref
Ida Johansson, Martin Lauss, Karolina Holm, Johan Staaf, Cecilia Nilsson, Marie-Louise Fjällskog, Markus Ringnér & Ingrid Hedenfalk. (2015) Genome methylation patterns in male breast cancer - Identification of an epitype with hypermethylation of polycomb target genes. Molecular Oncology 9:8, pages 1565-1579.
Crossref
Crossref
Susanne Hellerstedt-Börjesson, Karin Nordin, Marie-Louise Fjällskog, Inger K. Holmström & Cecilia Arving. (2015) Women With Breast Cancer. Cancer Nursing 38:1, pages 31-39.
Crossref
Crossref
Ida Johansson, Fredrika Killander, Barbro Linderholm & Ingrid Hedenfalk. (2014) Molecular profiling of male breast cancer – Lost in translation?. The International Journal of Biochemistry & Cell Biology 53, pages 526-535.
Crossref
Crossref
Frederik Wenz, Elena Sperk, Wilfried Budach, Jürgen Dunst, Petra Feyer, Rainer Fietkau, Wulf Haase, Wolfgang Harms, Marc D. Piroth, Marie-Luise Sautter-Bihl, Felix Sedlmayer, Rainer Souchon, Christoph Fussl & Rolf Sauer. (2014) DEGRO practical guidelines for radiotherapy of breast cancer IVDEGRO Leitlinien für die Radiotherapie des Mammakarzinoms IV. Strahlentherapie und Onkologie 190:8, pages 705-714.
Crossref
Crossref
Mike Kipling, Jane E.M. Ralph & Keith Callanan. (2014) Psychological Impact of Male Breast Disorders: Literature Review and Survey Results. Breast Care 9:1, pages 29-33.
Crossref
Crossref
Ida Johansson, Markus Ringnér & Ingrid Hedenfalk. (2013) The Landscape of Candidate Driver Genes Differs between Male and Female Breast Cancer. PLoS ONE 8:10, pages e78299.
Crossref
Crossref
Siddhartha Deb, Hongdo Do, David Byrne, Nicholas Jene, Alexander Dobrovic & Stephen B Fox. (2013) PIK3CA mutations are frequently observed in BRCAX but not BRCA2-associated male breast cancer. Breast Cancer Research 15:4.
Crossref
Crossref
Cecilia Nilsson, Anthoula Koliadi, Ida Johansson, Cecilia Ahlin, Sten Thorstenson, Leif Bergkvist, Ingrid Hedenfalk & Marie-Louise Fjällskog. (2013) High proliferation is associated with inferior outcome in male breast cancer patients. Modern Pathology 26:1, pages 87-94.
Crossref
Crossref
Siddhartha Deb, Nicholas Jene, kConFab investigators & Stephen B Fox. (2012) Genotypic and phenotypic analysis of familial male breast cancer shows under representation of the HER2 and basal subtypes in BRCA-associated carcinomas. BMC Cancer 12:1.
Crossref
Crossref
A.-C. Müller, C. Gani, H.M.E. Rehm, F. Eckert, M. Bamberg, T. Hehr & M. Weinmann. (2012) Are there biologic differences between male and female breast cancer explaining inferior outcome of men despite equal stage and treatment?!Bestehen biologische Unterschiede zwischen männlichem und weiblichem Brustkrebs, die das schlechtere Überleben von Männern trotz gleichen Stadiums und gleicher Behandlung erklären?!. Strahlentherapie und Onkologie 188:9, pages 782-787.
Crossref
Crossref
Ida Johansson, Cecilia Nilsson, Pontus Berglund, Martin Lauss, Markus Ringnér, Håkan Olsson, Lena Luts, Edith Sim, Sten Thorstensson, Marie-Louise Fjällskog & Ingrid Hedenfalk. (2012) Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker. Breast Cancer Research 14:1.
Crossref
Crossref